Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of November 12, 2025 is 16.21.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 20.90, which is 28.9% above the current share price.
  • The Amarin 52-week low stock price is 7.00, which is 56.8% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 12.84.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 13.2898 10.4000 20.2500 8.0000 16.2100 65.41%
2024 15.5571 17.8000 27.0000 8.8000 9.8000 -43.68%
2023 24.4864 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0905 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3060 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3665 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8524 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1444 22.6000 58.0000 20.0000 37.8000 92.86%
2014 30.3952 39.2000 48.0000 16.6000 19.6000 -50.25%
2013 118.1913 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6416 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0810 166.6000 390.0000 120.6000 149.8000 -8.66%
2010 53.0810 27.6000 169.8000 19.6000 164.0000 473.43%
2009 23.8532 13.6000 39.0000 10.4000 28.6000 101.41%
2008 38.0245 50.0000 71.8000 12.0000 14.2000 -72.69%
2007 200.2550 436.0000 756.0000 46.0000 52.0000 -88.60%
2006 522.9402 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4365 524.0000 680.0000 212.0000 240.0000 -55.72%
2004 277.9286 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.2778 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1681.3175 3420.0000 4200.0000 552.0000 798.0000 -77.03%
2001 2655.0358 1100.0000 5594.0000 1000.0000 3474.0000 215.82%
2000 1195.6349 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1408.1349 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2068.5020 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10047.1838 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 16968.1350 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14550.3472 13000.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15457.9623 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.333B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $276.304B 19.50
Amgen (AMGN) United States $182.249B 15.48
Gilead Sciences (GILD) United States $152.058B 14.97
Vertex Pharmaceuticals (VRTX) United States $108.901B 28.03
Bristol Myers Squibb (BMY) United States $99.182B 7.43
GSK (GSK) United Kingdom $98.292B 10.93
Regeneron Pharmaceuticals (REGN) United States $70.895B 18.39
Alnylam Pharmaceuticals (ALNY) United States $59.709B 1965.00
CSL (CSLLY) Australia $56.394B 0.00
Argenex SE (ARGX) Netherlands $54.774B 68.01
Insmed (INSM) United States $41.309B 0.00
Novozymes (NVZMY) Denmark $30.912B 0.00
BioNTech SE (BNTX) Germany $26.125B 0.00
Biogen (BIIB) United States $23.408B 9.53
Royalty Pharma (RPRX) United States $22.720B 8.62
Incyte (INCY) United States $21.234B 20.33
Genmab (GMAB) Denmark $19.461B 14.64
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.733B 28.12
Roivant Sciences (ROIV) United Kingdom $14.272B 0.00
Exact Sciences (EXAS) United States $12.789B 355.26
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.411B 0.00
Revolution Medicines (RVMD) United States $12.388B 0.00
Guardant Health (GH) United States $12.315B 0.00
Exelixis (EXEL) United States $11.522B 18.44
Avidity Biosciences (RNA) United States $10.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.553B 19.14
Moderna (MRNA) United States $10.318B 0.00
QIAGEN (QGEN) Netherlands $9.830B 18.66
Bio-Techne Corp (TECH) United States $9.221B 34.41
Repligen (RGEN) United States $8.637B 92.43
Abivax SA (ABVX) France $8.488B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.332B 32.49
Halozyme Therapeutics (HALO) United States $8.247B 13.18
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Cytokinetics (CYTK) United States $8.131B 0.00
Metsera (MTSR) United States $7.455B 0.00
Merus (MRUS) Netherlands $7.242B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.190B 0.00
Axsome Therapeutics (AXSM) United States $7.038B 0.00
Nuvalent (NUVL) United States $6.991B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.664B 0.00
Vaxcyte (PCVX) United States $5.977B 0.00
PTC Therapeutics (PTCT) United States $5.927B 8.05
Legend Biotech (LEGN) United States $5.912B 0.00
Krystal Biotech (KRYS) United States $5.887B 30.43
Arrowhead Pharmaceuticals (ARWR) United States $5.738B 0.00
Alkermes (ALKS) Ireland $5.583B 16.41
Protagonist Therapeutics (PTGX) United States $5.349B 138.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.262B 0.00
Arcellx (ACLX) United States $5.217B 0.00
Zealand Pharma (ZLDPF) Denmark $5.205B 5.15
TG Therapeutics (TGTX) United States $4.939B 11.19
Cogent Biosciences (COGT) United States $4.758B 0.00
Praxis Precision Medicines (PRAX) United States $4.590B 0.00
Viking Therapeutics (VKTX) United States $4.589B 0.00
Kymera Therapeutics (KYMR) United States $4.559B 0.00
Akero Therapeutics (AKRO) United States $4.466B 0.00
Ligand Pharmaceuticals (LGND) United States $4.108B 100.82
ACADIA Pharmaceuticals (ACAD) United States $4.013B 33.89
Immunovant (IMVT) United States $4.012B 0.00
ADMA Biologics Inc (ADMA) United States $3.825B 27.17
Mineralys Therapeutics (MLYS) United States $3.728B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.665B 0.00
Telix Pharmaceuticals (TLX) Australia $3.463B 0.00
Cidara Therapeutics (CDTX) United States $3.401B 0.00
Belite Bio (BLTE) United States $3.367B 0.00
Celcuity (CELC) United States $3.359B 0.00
Anbio Biotechnology (NNNN) Germany $3.328B 0.00
Travere Therapeutics (TVTX) United States $3.231B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.211B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.208B 0.00
Jyong Biotech (MENS) Taiwan $3.091B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.085B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.075B 90.16
GRAIL (GRAL) United States $3.006B 0.00
Disc Medicine (IRON) United States $2.992B 0.00
Ascentage Pharma Group - (AAPG) China $2.990B 0.00
CG Oncology (CGON) United States $2.961B 0.00
Scholar Rock Holding (SRRK) United States $2.960B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.943B 0.00
Apogee Therapeutics (APGE) United States $2.903B 0.00
Amicus Therapeutics (FOLD) United States $2.876B 233.00
IDEAYA Biosciences (IDYA) United States $2.806B 0.00
Viridian Therapeutics (VRDN) United States $2.713B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.658B 0.00
Denali Therapeutics (DNLI) United States $2.578B 0.00
Agios Pharmaceuticals (AGIO) United States $2.558B 0.00
Apellis Pharmaceuticals (APLS) United States $2.469B 62.94
Zai Lab (ZLAB) China $2.459B 0.00
Liquidia (LQDA) United States $2.417B 0.00
Bavarian Nordic (BVNRY) Denmark $2.327B 11.25
Beam Therapeutics (BEAM) United States $2.281B 0.00
Edgewise Therapeutics (EWTX) United States $2.274B 0.00
Adaptive Biotechnologies (ADPT) United States $2.218B 0.00
Arcus Biosciences (RCUS) United States $2.191B 0.00
ImmunityBio (IBRX) United States $2.108B 0.00
Vericel (VCEL) United States $2.076B 171.04
Recursion Pharmaceuticals (RXRX) United States $2.045B 0.00
Structure Therapeutics (GPCR) United States $2.008B 0.00
Mesoblast (MESO) Australia $1.992B 0.00
ANI Pharmaceuticals (ANIP) United States $1.921B 15.43
UniQure (QURE) Netherlands $1.921B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.900B 10.37
Vera Therapeutics (VERA) United States $1.896B 0.00
Twist Bioscience (TWST) United States $1.891B 0.00
Sarepta Therapeutics (SRPT) United States $1.884B 0.00
Terns Pharmaceuticals (TERN) United States $1.854B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.774B 0.00
Janux Therapeutics (JANX) United States $1.736B 0.00
Nuvation Bio (NUVB) United States $1.707B 0.00
Alvotech (ALVO) Luxembourg $1.682B 12.68
Sionna Therapeutics (SION) United States $1.627B 0.00
Celldex Therapeutics (CLDX) United States $1.619B 0.00
MannKind (MNKD) United States $1.612B 52.50
Immunome (IMNM) United States $1.607B 0.00
Maze Therapeutics (MAZE) United States $1.552B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.541B 0.00
Zenas BioPharma (ZBIO) United States $1.482B 0.00
Trevi Therapeutics (TRVI) United States $1.474B 0.00
Zymeworks (ZYME) United States $1.473B 0.00
Stoke Therapeutics (STOK) United States $1.434B 37.48
Spyre Therapeutics (SYRE) United States $1.410B 0.00
Certara (CERT) United States $1.367B 25.24
NeoGenomics (NEO) United States $1.348B 0.00
NovoCure (NVCR) Jersey $1.328B 0.00
Dynavax Technologies (DVAX) United States $1.323B 38.86
Upstream Bio (UPB) United States $1.285B 0.00
Pharvaris (PHVS) Netherlands $1.261B 0.00
Oric Pharmaceuticals (ORIC) United States $1.251B 0.00
WAVE Life Sciences (WVE) Singapore $1.214B 0.00
Novavax (NVAX) United States $1.209B 3.07
AbCellera Biologics (ABCL) Canada $1.200B 0.00
CureVac (CVAC) Germany $1.185B 5.50
Precigen (PGEN) United States $1.180B 0.00
Intellia Therapeutics (NTLA) United States $1.179B 0.00
Dianthus Therapeutics (DNTH) United States $1.162B 0.00
Sana Biotechnology (SANA) United States $1.129B 0.00
Tango Therapeutics (TNGX) United States $1.128B 0.00
Inhibrx Biosciences (INBX) United States $1.128B 0.00
Immatics (IMTX) Germany $1.117B 0.00
MiMedx (MDXG) United States $1.117B 19.84
Urogen Pharma (URGN) United States $1.106B 0.00
Fortrea Holdings (FTRE) United States $1.089B 23.12
Pharming Group (PHAR) Netherlands $1.082B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.064B 0.00
Iovance Biotherapeutics (IOVA) United States $1.052B 0.00
Pacira BioSciences (PCRX) United States $1.038B 11.88
Kodiak Sciences (KOD) United States $1.037B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Phathom Pharmaceuticals (PHAT) United States $1.022B 0.00
Castle Biosciences (CSTL) United States $1.021B 139.88
Oculis Holding AG (OCS) Switzerland $1.016B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $1.010B 0.00
Nanobiotix S.A - (NBTX) France $1.003B 0.00
Nurix Therapeutics (NRIX) United States $0.989B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.964B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.950B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.932B 44.75
Rezolute (RZLT) United States $0.931B 0.00
BGM Group (BGM) China $0.931B 0.00
Rapport Therapeutics (RAPP) United States $0.931B 0.00
Kura Oncology (KURA) United States $0.930B 0.00
AnaptysBio (ANAB) United States $0.929B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Arbutus Biopharma (ABUS) United States $0.903B 0.00
Biohaven (BHVN) United States $0.902B 0.00
CorMedix Inc (CRMD) United States $0.877B 14.92
Septerna (SEPN) United States $0.861B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.837B 0.00
LENZ Therapeutics (LENZ) United States $0.828B 0.00
Tyra Biosciences (TYRA) United States $0.808B 0.00
Bicara Therapeutics (BCAX) United States $0.807B 0.00
ArriVent BioPharma (AVBP) United States $0.800B 0.00
Geron (GERN) United States $0.798B 0.00
Vir Biotechnology (VIR) United States $0.794B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.772B 100.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.755B 0.00
GH Research (GHRS) Ireland $0.740B 0.00
Arvinas (ARVN) United States $0.720B 0.00
Replimune (REPL) United States $0.716B 0.00
MeiraGTx Holdings (MGTX) United States $0.716B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
CytomX Therapeutics (CTMX) United States $0.695B 10.25
Ventyx Biosciences (VTYX) United States $0.673B 0.00
Erasca (ERAS) United States $0.669B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Compass Therapeutics (CMPX) United States $0.640B 0.00
MapLight Therapeutics (MPLT) $0.624B 0.00
Myriad Genetics (MYGN) United States $0.623B 0.00
Cytek Biosciences (CTKB) United States $0.612B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.610B 0.00
Gossamer Bio (GOSS) United States $0.599B 0.00
Anavex Life Sciences (AVXL) United States $0.588B 0.00
REGENXBIO (RGNX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Emergent Biosolutions (EBS) United States $0.571B 5.49
Niagen Bioscience (NAGE) United States $0.571B 44.75
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Verastem (VSTM) United States $0.564B 0.00
Prothena (PRTA) Ireland $0.564B 0.00
Olema Pharmaceuticals (OLMA) United States $0.562B 0.00
Alumis (ALMS) United States $0.552B 0.00
Inventiva S.A (IVA) France $0.539B 0.00
Prime Medicine (PRME) United States $0.528B 0.00
Absci (ABSI) United States $0.516B 0.00
Keros Therapeutics (KROS) United States $0.515B 10.97
Monopar Therapeutics (MNPR) United States $0.515B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.501B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.492B 0.00
NovaBridge Biosciences (NBP) United States $0.488B 0.00
Rapt Therapeutics (RAPT) United States $0.488B 0.00
Eton Pharmaceuticals (ETON) United States $0.474B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.473B 0.00
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Neumora Therapeutics (NMRA) United States $0.459B 0.00
EnGene Holdings (ENGN) Canada $0.452B 0.00
DBV Technologies S.A (DBVT) France $0.451B 0.00
Design Therapeutics (DSGN) United States $0.442B 0.00
Fulcrum Therapeutics (FULC) United States $0.441B 0.00
Neurogene (NGNE) United States $0.441B 0.00
Bright Minds Biosciences (DRUG) United States $0.417B 0.00
XOMA Royalty (XOMA) United States $0.417B 0.00
Ocugen (OCGN) United States $0.415B 0.00
Kamada (KMDA) Israel $0.406B 19.61
LB Pharmaceuticals Inc (LBRX) United States $0.404B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.399B 0.00
PureTech Health (PRTC) United States $0.395B 0.00
Invivyd (IVVD) United States $0.385B 0.00
Northwest Biotherapeutics (NWBO) United States $0.368B 0.00
Alto Neuroscience (ANRO) United States $0.363B 0.00
Annexon (ANNX) United States $0.355B 0.00
Tectonic Therapeutic (TECX) United States $0.355B 0.00
Solid Biosciences (SLDB) United States $0.353B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.352B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
AC Immune (ACIU) Switzerland $0.340B 0.00
DiaMedica Therapeutics (DMAC) United States $0.330B 0.00
Contineum Therapeutics (CTNM) United States $0.320B 0.00
Jade Biosciences (JBIO) United States $0.320B 0.00
Kyverna Therapeutics (KYTX) United States $0.303B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.297B 0.00
Entrada Therapeutics (TRDA) United States $0.294B 0.00
Lifecore Biomedical (LFCR) United States $0.290B 0.00
Zura Bio (ZURA) United States $0.287B 0.00
BioAge Labs (BIOA) United States $0.281B 0.00
Immuneering (IMRX) United States $0.280B 0.00
Allogene Therapeutics (ALLO) United States $0.279B 0.00
Sagimet Biosciences (SGMT) United States $0.276B 0.00
Candel Therapeutics (CADL) United States $0.276B 0.00
Palisade Bio (PALI) United States $0.271B 0.00
Atea Pharmaceuticals (AVIR) United States $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.263B 12.83
Alpha Teknova (TKNO) United States $0.262B 0.00
Prima BioMed (IMMP) Australia $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.262B 7.01
Editas Medicine (EDIT) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.251B 0.00
Aardvark Therapeutics (AARD) United States $0.240B 0.00
Cabaletta Bio (CABA) United States $0.238B 0.00
Voyager Therapeutics (VYGR) United States $0.237B 0.00
Tenaya Therapeutics (TNYA) United States $0.236B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.235B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.235B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.232B 0.00
Genelux (GNLX) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
Adherex Technologies (FENC) United States $0.223B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.218B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.214B 4.53
Nautilus Biotechnology (NAUT) United States $0.210B 0.00
Caribou Biosciences (CRBU) United States $0.209B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.203B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Humacyte (HUMA) United States $0.203B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Cartesian Therapeutics (RNAC) United States $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.189B 0.00
Crescent Biopharma (CBIO) United States $0.184B 0.00
C4 Therapeutics (CCCC) United States $0.177B 0.00
Forte Biosciences (FBRX) United States $0.175B 0.00
Sangamo Therapeutics (SGMO) United States $0.169B 0.00
MaxCyte (MXCT) United States $0.165B 0.00
Coherus Oncology (CHRS) United States $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Codexis (CDXS) United States $0.163B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.155B 0.00
Cognition Therapeutics (CGTX) United States $0.154B 0.00
Cardiff Oncology (CRDF) United States $0.154B 0.00
Compugen (CGEN) Israel $0.153B 0.00
PepGen (PEPG) United States $0.153B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.151B 0.00
Alector (ALEC) United States $0.148B 0.00
Spero Therapeutics (SPRO) United States $0.147B 0.00
Anika Therapeutics (ANIK) United States $0.146B 0.00
Agenus (AGEN) United States $0.145B 0.00
Actuate Therapeutics (ACTU) United States $0.144B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Nkarta (NKTX) United States $0.143B 0.00
Rani Therapeutics Holdings (RANI) United States $0.139B 0.00
Entera Bio (ENTX) Israel $0.137B 0.00
Seres Therapeutics (MCRB) United States $0.135B 0.00
Applied Therapeutics (APLT) United States $0.133B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
Fate Therapeutics (FATE) United States $0.129B 0.00
Opus Genetics (IRD) United States $0.128B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.128B 0.00
EXoZymes (EXOZ) United States $0.127B 0.00
VistaGen Therapeutics (VTGN) United States $0.124B 0.00
TuHURA Biosciences (HURA) United States $0.122B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.119B 0.00
Greenwich LifeSciences (GLSI) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.115B 0.00
Citius Oncology (CTOR) United States $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
InflaRx (IFRX) Germany $0.111B 0.00
Turn Therapeutics (TTRX) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.108B 0.00
Oncolytics Biotech (ONCY) Canada $0.108B 0.00
Inovio Pharmaceuticals (INO) United States $0.107B 0.00
Instil Bio (TIL) United States $0.106B 0.00
Whitehawk Therapeutics (WHWK) United States $0.105B 0.00
OKYO Pharma (OKYO) $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.103B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.100B 0.00
Biomea Fusion (BMEA) United States $0.099B 0.00
Starpharma Holdings (SPHRY) Australia $0.098B 0.00
Clene (CLNN) United States $0.096B 0.00
Quince Therapeutics (QNCX) United States $0.096B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.096B 0.00
Ovid Therapeutics (OVID) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Kalaris Therapeutics (KLRS) United States $0.095B 0.00
Estrella Immunopharma (ESLA) United States $0.093B 0.00
Tevogen Bio Holdings (TVGN) United States $0.092B 0.00
XBiotech (XBIT) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Atara Biotherapeutics (ATRA) United States $0.088B 0.00
Artiva Biotherapeutics (ARTV) United States $0.088B 0.00
Chrome Holding (MEHCQ) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
CAMP4 Therapeutics (CAMP) United States $0.083B 0.00
Adagene (ADAG) China $0.080B 0.00
Fortress Biotech (FBIO) United States $0.080B 0.00
Precision BioSciences (DTIL) United States $0.080B 0.00
ATyr Pharma (ATYR) United States $0.077B 0.00
Immunic (IMUX) United States $0.077B 0.00
BioStem Technologies (BSEM) $0.077B 4.01
Repare Therapeutics (RPTX) Canada $0.074B 0.00
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
TScan Therapeutics (TCRX) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.069B 0.00
Vor Biopharma (VOR) $0.067B 0.00
CervoMed (CRVO) United States $0.064B 0.00
MiNK Therapeutics (INKT) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.060B 0.00
Equillium (EQ) United States $0.058B 0.00
Spruce Biosciences (SPRB) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Adicet Bio (ACET) United States $0.054B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
PDS Biotechnology (PDSB) United States $0.050B 0.00
Senti Biosciences (SNTI) United States $0.048B 0.00
TELA Bio (TELA) United States $0.047B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
CalciMedica (CALC) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Radiopharm Theranostics - (RADX) Australia $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
X4 Pharmaceuticals (XFOR) United States $0.040B 0.00
INmune Bio (INMB) United States $0.040B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
BioAtla (BCAB) United States $0.040B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Hyperion DeFi (HYPD) United States $0.039B 0.00
RenovoRx (RNXT) United States $0.039B 0.00
Generation Bio (GBIO) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Dyadic (DYAI) United States $0.035B 0.00
Elutia (ELUT) United States $0.035B 0.00
Rein Therapeutics (RNTX) United States $0.035B 0.00
ImageneBio (IMA) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Alterity Therapeutics - (ATHE) Australia $0.033B 0.00
BioXcel Therapeutics (BTAI) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Galecto (GLTO) Denmark $0.031B 0.00
Q32 Bio (QTTB) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Rallybio (RLYB) United States $0.030B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Jasper Therapeutics (JSPR) United States $0.028B 0.00
Synaptogenix (TAOX) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.025B 0.00
IBio (IBIO) United States $0.025B 0.00
Tharimmune (THAR) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
Intensity Therapeutics (INTS) United States $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Clearside Biomedical (CLSD) United States $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
MetaVia (MTVA) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
NewcelX (NCEL) Switzerland $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Apollomics (APLM) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
Longeveron (LGVN) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Cocrystal Pharma (COCP) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Imunon (IMNN) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Black Titan (BTTC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GT Biopharma (GTBP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Alps Group (ALPS) United States $0.002B 1.82
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00